IL6 and ovarian cancer: ↔ 506 DVT vs. 1464 controls (37) −174 CC ↑ SNP: 108 VTE vs. 325 controls (36) −174 G > C ↑ SNP: 130 DVT+ and 190 DVT− (cancer patients) vs. 215 controls (39) −174 GC ↑ SNP: 119 VTE vs. 126 controls (40) −174 G > C ↔ SNP: 128 DVT, 105 PE vs. 122 controls ↔ IL6: 128 DVT, 105 PE vs. 122 controls (41) CC −572 G/C ↑ 140/246 VTE vs. 160/292 controls, respectively (42, 43) ↑IL6, 200 ovarian cancer, predictor for VTE (44) ↑IL6 in 34 VTE 322 patients with diffuse large B-cell lymphoma (45)